In yesterday’s Wall Street session, Walgreens Boots Alliance Inc (NASDAQ:WBA) shares traded at $21.03, down -0.90% from the previous session.
As of this writing, 16 analysts cover Walgreens Boots Alliance Inc (NASDAQ:WBA). The consensus rating among analysts is ‘Hold’. WBA stock price is now -3.08% away from the 50-day moving average and -28.11% away from the 200-day moving average. The market capitalization of the company currently stands at $18.17B.
There are 11 analysts who have given it a hold rating, whereas 3 have given it a buy rating.
With the price target enhanced from $27 to $30, JP Morgan Upgraded its rating from Neutral to Overweight for Walgreens Boots Alliance Inc (NASDAQ: WBA).
In other news, Gates Richard P., SVP, Chief Pharmacy Officer sold 1,000 shares of the company’s stock on Nov 10. The stock was sold for $20,450 at an average price of $20.45. Upon completion of the transaction, the SVP, Chief Pharmacy Officer now directly owns 73,929 shares in the company, valued at $1.55 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 09, 10% Owner Walgreens Boots Alliance, Inc. sold 1,279,590 shares of the business’s stock. A total of $249,999,896 was realized by selling the stock at an average price of $195.38. This leaves the insider owning 30,489,956 shares of the company worth $641.2 million. Insiders disposed of 49,805 shares of company stock worth roughly $1.05 million over the past 1 year. A total of 17.48% of the company’s stock is owned by insiders.
Monday morning saw Walgreens Boots Alliance Inc (NASDAQ: WBA) opened at $21.14. During the past 12 months, Walgreens Boots Alliance Inc has had a low of $20.00 and a high of $42.29. As of last week, the company has a debt-to-equity ratio of 1.72, a current ratio of 0.63, and a quick ratio of 0.30. The fifty day moving average price for WBA is $21.70 and a two-hundred day moving average price translates $29.25 for the stock.
The latest earnings results from Walgreens Boots Alliance Inc (NASDAQ: WBA) was released for Aug, 2023. According to the Pharmaceutical Retailers Company, earnings per share came in at $0.67, missing analysts’ expectations of $0.69 by -0.02. This compares to -$0.26 EPS in the same period last year. The net profit margin was -2.21% and return on equity was -13.61% for WBA. The company reported revenue of $35.42 billion for the quarter, compared to $32.45 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 9.16 percent. For the current quarter, analysts expect WBA to generate $34.85B in revenue.
Walgreens Boots Alliance Inc(WBA) Company Profile
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients’ homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.